Quarterlytics / Industries / Healthcare / Biotechnology
Industry
Healthcare

Biotechnology

446 companies in this industry — from early-stage micro-caps to established names the market already covers.

446companies 30pages Healthcare
Companies covered 446
Sector Healthcare
Industry Biotechnology
Latest filing —
Coverage Updated weekly
Exchange Sort
Showing 15 of 446 companies Page 18 of 30
LIXT NASDAQ · 2 emp.

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common...

Biotechnology
MAZE NASDAQ · 125 emp.

Maze Therapeutics, Inc.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, ...

Biotechnology
CRBU NASDAQ · 147 emp.

Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatmen...

Biotechnology
CCCC NASDAQ · 110 emp.

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatmen...

Biotechnology
DMRA NASDAQ · 7 emp.

Galecto, Inc.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biolog...

Biotechnology
GNLX NASDAQ · 24 emp.

Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering...

Biotechnology
LYEL NASDAQ · 300 emp.

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapi...

Biotechnology
LXEO NASDAQ · 75 emp.

Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006,...

Biotechnology
VOR NASDAQ · 159 emp.

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an e...

Biotechnology
GANX NASDAQ · 23 emp.

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare ...

Biotechnology
TLSA NASDAQ · 9 emp.

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology....

AKTS NASDAQ · 79 emp.

Aktis Oncology, Inc.

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treat...

EPRX NASDAQ · 33 emp.

Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnol...

Biotechnology
MGTX NASDAQ · 375 emp.

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops vari...

BIOA NASDAQ · 62 emp.

BioAge Labs, Inc.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology...

Biotechnology
‹ 1 … 17 18 19 … 30 ›
Healthcare · Biotechnology coverage

The whole industry,
in one read.

We publish original research across all biotechnology companies — profiles, earnings reports and news on the small- and mid-caps the market overlooks. 446 companies, permanently indexed. Free to read.

All Healthcare companies → Browse all industries →
Editorial photograph